Browse by Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 120.

Article

McGill, Margaret; Blonde, Lawrence; Chan, Juliana C.N.; Khunti, Kamlesh; Lavalle, Fernando J. and Bailey, Clifford J. (2017). The interdisciplinary team in type 2 diabetes management:challenges and best practice solutions from real-world scenarios. Journal of Clinical and Translational Endocrinology, 7 , pp. 21-27.

Evans, Mark; Cranston, Iain and Bailey, Clifford J. (2017). Ambulatory glucose profile (AGP):utility in UK clinical practice. British Journal of Diabetes and Vascular Disease, 17 (1), pp. 26-33.

Tahrani, Abd A.; Barnett, Anthony H. and Bailey, Clifford J. (2016). Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature Reviews Endocrinology, 12 (10), 566–592.

McCreight, Laura J.; Bailey, Clifford J. and Pearson, Ewan R. (2016). Metformin and the gastrointestinal tract. Diabetologia, 59 (3), pp. 426-435.

Pararasa, Chathyan; Ikwuobe, John; Shigdar, Shahjahan; Boukouvalas, Alexis; Nabney, Ian T.; Brown, James E.; Devitt, Andrew; Bailey, Clifford J.; Bennett, Stuart J. and Griffiths, Helen R. (2016). Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell, 15 (1), pp. 128-139.

Bailey, Clifford J. (2016). Timely intervention in type 2 diabetes:achieving early and sustained glycemic control. Medicographia, 38 (1), pp. 3-8.

Wilding, J.P.H.; Bailey, C.J.; Rigney, U.; Blak, B.; Beekman, W. and Emmas, C.E. (2015). Changes in HbA1c and weight in type 2 diabetes patients initiating dapagliflozin treatment in routine UK primary care. Diabetologia, 58 (Suppl.), S352-S356.

Bailey, C.J. (2015). Safety of antidiabetes medications:an update. Clinical pharmacology and therapeutics, 98 (2), 185–195.

Bailey, C.J.; Morales Villegas, E.C.; Woo, V.; Tang, W.; Ptaszynska, A. and List, J.F. (2015). Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes:a randomized double-blind placebo-controlled 102-week trial. Diabetic Medicine, 32 (4), pp. 531-541.

Qureshi, Khalid M.; Lee, Jou; Paget, Michelle B.; Bailey, Clifford J.; Curnow, S. John; Murray, Hilary E. and Downing, Richard (2015). Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity. Clinical Transplantation, 29 (1), pp. 90-98.

Day, Caroline and Bailey, Clifford J. (2015). Pharmacotherapies to manage diabesity:an update. Diabesity in practice, 4 (1), pp. 14-23.

Home, Philip; Riddle, Matthew; Cefalu, William T.; Bailey, Clifford J.; Bretzel, Reinhard G.; del Prato, Stefano; Leroith, Derek; Schernthaner, Guntram; van Gaal, Luc and Raz, Itamar (2014). Response to comment on Home et al. Insulin therapy in people with type 2 diabetes:opportunities and challenges? Diabetes care 2014;37:1499-1508. Diabetes Care, 37 (11),

Pararasa, Chathyan; Bailey, Clifford and Griffiths, Helen (2014). Macrophage polarisation by fatty acids is PPARgamma-dependent. Free Radical Biology and Medicine, 75 (Suppl.), S31-S32.

Bailey, Clifford J.; Azar, S.T.; Blonde, Lawrence; Dicker, D.; Puig-domingo, M; Eliaschewitz, F.G.; Nikonova, E.; Roussel, R.; Sakaguchi, K; Sauque-Reyna, L and Nauck, M. (2014). Relationship between changes in postprandial glucagon, patient characteristics, and response to lixisenatide as add-on to oral antidiabetics. Diabetologia, 57 (Suppl.), S344.

Fouqueray, Pascale; Pirags, Valdis; Diamant, Michaela; Schernthaner, Guntram; Lebovitz, Harold E.; Inzucchi, Silvio E. and Bailey, Clifford J. (2014). The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy. Diabetes Care, 37 (7), pp. 1924-1930.

Al-Khattawi, Ali; Iyire, Affiong; Dennison, Tom; Dahmash, Eman; Bailey, Clifford J; Smith, Julian; Rue, Peter and Mohammed, Afzal R. (2014). Systematic screening of compressed ODT excipients : cellulosic versus non-cellulosic. Current drug delivery, 11 , pp. 1-15.

Al-Khattawi, Ali; Iyire, Affiong; Dennison, Tom; Dahmash, Eman; Bailey, Clifford J.; Smith, Julian; Rue, Peter and Mohammed, Afzal R. (2014). Systematic screening of compressed ODT excipients:cellulosic versus non-cellulosic. Current Drug Delivery, 11 (4), pp. 486-500.

Rana, K.; Hill, E.J.; Bailey, C.J.; Bellary, S. and Brown, J.E. (2014). Association between body composition, circulating irisin and telomere length in healthy individuals and individuals with Type 2 diabetes. Diabetic Medicine, 31 (s1), p. 38.

Paget, Michelle B.; Murray, Hilary E.; Bailey, Clifford J. and Downing, Richard (2013). Pre-transplant signal induction for vascularisation in human islets. Diabetes and Vascular Disease Research, 10 (6), pp. 536-545.

Bailey, C.J.; Berria, R.; Stager, W.; Gautier, J.-F.; Aronson, R. and Ahrén, B. (2013). Consistent reduction of postprandial glucagon and insulin by lixisenatide in the GetGoal clinical trial programme. Diabetologia, 56 (Suppl.), S403.

Bailey, Clifford J. (2013). Interpreting adverse signals in diabetes drug development programs. Diabetes Care, 36 (7), pp. 2098-2106.

Day, Caroline; Campbell, Ian W. and Bailey, Clifford J. (2013). Free to publish - free to read. British Journal of Diabetes and Vascular Disease, 13 (4), pp. 162-163.

Choudry, N.; Robinson, J.; Arif, M.; Rana, K.S.; Hill, E.J.; Turner, S.; Bailey, C.J. and Brown, J.E. (2013). Phytoestrogen-ind uced glucose uptake and cellular proliferation in L6 myotubesadipocyte function. Diabetic Medicine, 30 (S1), p. 39.

Bailey, C.J.; Wilding, J.; Nauck, M.A.; Ferranninin, E.; Ptaszynska, A.A.; Apanovitch, A.M.; Sugg, J. and Parikh, S.J. (2012). Sustained reductions in weight and HbA1c with dapagliflozin: long-term results from phase III clinical studies in type 2 diabetes. Diabetologia, 55 (Suppl.), S295.

Pararasa, C.; Gao, D.; Dunston, C.R.; Bailey, C.J. and Griffiths, H.R. (2012). Palmitate induces phenotype changes in monocytes via de novo ceramide synthesis. Free Radical Biology and Medicine, 53 (Supple), S136.

Gao, Dan; Pararasa, Chathyan; Dunston, Christopher R; Bailey, Clifford J. and Griffiths, Helen R. (2012). Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. Free Radical Biology and Medicine, 53 (4), 796–806.

Bailey, Clifford J. (2012). Diabetes : insulin plus metformin for T2DM-are there benefits? Nature Reviews Endocrinology, 8 (8), pp. 449-450.

Bailey, Clifford J. and Day, Caroline (2012). Diabetes therapies in renal impairment. British Journal of Diabetes and Vascular Disease, 12 (4), pp. 167-171.

Bailey, Clifford J.; Day, Caroline; Campbell, Ian W. and Schindler, Christoph (2012). Glycaemic control and cardiovascular outcome trials in type 2 diabetes. British Journal of Diabetes and Vascular Disease, 12 (4), pp. 161-164.

Tahrani, Abd A.; Bailey, Clifford J. and Barnett, Anthony H. (2012). Insulin degludec:a new ultra-longacting insulin. The Lancet, 379 (9825), pp. 1465-1467.

Bailey, Clifford J (2012). Could FFAR1 assist insulin secretion in type 2 diabetes? The Lancet, 379 (9824), pp. 1370-1371.

Bailey, Clifford J. and Day, Caroline (2012). Anti-obesity fixed-dose combinations. British Journal of Diabetes and Vascular Disease, 12 (1), pp. 2-5.

Day, Caroline and Bailey, Clifford J. (2012). The hypocaloric diet in type 2 diabetes - déjà vu. British Journal of Diabetes and Vascular Disease, 12 (1), pp. 48-51.

Bailey, Clifford J. (2011). The challenge of managing coexistent type 2 diabetes and obesity. BMJ, 342 (7803),

Bailey, C.J.; Gross, J.L.; Yadav, M.; Iqbal, N.; Mansfield, T.A. and List, J.F. (2011). Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy. Diabetologia, 54 (S1), S67.

Tahrani, Abd A.; Bailey, Clifford J; Del Prato, Stefano and Barnett, Anthony H. (2011). Management of type 2 diabetes:new and future developments in treatment. The Lancet, 378 (9786), pp. 182-197.

Paget, M.B.; Murray, H.E.; Bailey, C.J.; Flatt, P.R. and Downing, R. (2011). Rotational co-culture of clonal β-cells with endothelial cells:effect of PPAR-γ agonism in vitro on insulin and VEGF secretion. Diabetes, Obesity and Metabolism, 13 (7), pp. 662-668.

Lipska, Kasia J; Bailey, Clifford J and Inzucchi, Silvio E (2011). Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care, 34 (6), pp. 1431-1437.

Irwin, N.; McKinney, J.M.; Bailey, C.J.; McClenaghan, N.H. and Flatt, P.R. (2011). Acute and long-term effects of peroxisome proliferator-activated receptor-γ activation on the function and insulin secretory responsiveness of clonal beta-cells. Hormone and Metabolic Research, 43 (4), pp. 244-249.

Ramachandran, S.; Saraf, S.; Shetty, C.; Capps, N. and Bailey, C. (2011). Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes. Annals of Clinical Biochemistry, 48 (1), pp. 75-78.

Qureshi, Khalid M.; Oliver, Robert J.; Paget, Michelle B; Murray, Hilary E; Bailey, Clifford J. and Downing, Richard (2011). Human amniotic epithelial cells induce localized cell-mediated immune privilege in vitro:implications for pancreatic islet transplantation. Cell Transplantation, 20 (4), pp. 523-534.

Holt, R.I.G.; Barnett, A.H. and Bailey, C.J. (2010). Bromocriptine:old drug, new formulation and new indication. Diabetes, Obesity and Metabolism, 12 (12), pp. 1048-1057.

Irwin, N.; McKinney, J.M.; Bailey, C.J.; Flatt, P.R. and McClenaghan, N.H. (2010). Effects of metformin on BRIN-BD11 beta-cell insulin secretory desensitization induced by prolonged exposure to sulphonylureas. Diabetes, Obesity and Metabolism, 12 (12), pp. 1066-1071.

Bailey, Clifford J.; Green, Brian D. and Flatt, Peter R. (2010). Fixed-dose combination therapy for type 2 diabetes:sitagliptin plus pioglitazone. Expert Opinion on Investigational Drugs: authoritative analysis of r and d trends, 19 (8), pp. 1017-1025.

Bailey, Clifford J. and Barnett, Anthony H. (2010). Inhaled insulin:new formulation, new trial. The Lancet, 375 (9733), pp. 2199-201.

Bailey, Clifford J.; Gross, Jorge L.; Pieters, Anne; Bastien, Arnaud and List, James F. (2010). Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin:a randomised, double-blind, placebo-controlled trial. The Lancet, 375 (9733), pp. 2223-2233.

Bailey, Clifford J. and Day, Caroline (2010). Hypoglycaemia:a limiting factor. British Journal of Diabetes and Vascular Disease, 10 (1), pp. 2-4.

Del Prato, Stefano; LaSalle, J.; Matthaei, S.; Bailey, Clifford and , Global Partnership for Effective Diabetes Management (2010). Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. International Journal of Clinical Practice, 64 (3), pp. 295-304.

Gao, Dan; Bailey, Clifford J. and Griffiths, Helen R. (2009). Metabolic memory effect of the saturated fatty acid, palmitate, in monocytes. Biochemical and Biophysical Research Communications, 388 (2), pp. 278-282.

Kerr, Barry D; Irwin, Nigel; O'Harte, Finbarr P M; Bailey, Clifford J; Flatt, Peter R and Gault, Victor A (2009). Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Biochemical Pharmacology, 78 (8), pp. 1008-1016.

Bailey, Clifford J (2009). New therapies for diabesity. Current Diabetes Reports, 9 (5), pp. 360-367.

Bailey, Clifford J; Blonde, Lawrence; Del Prato, Stefano; Leiter, Lawrence A; Nesto, Richard and , Global Partnership for Effective Diabetes Management (2009). What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management. Diabetes and Vascular Disease Research, 6 (4), pp. 283-287.

Tan, Bee K.; Chen, Jing; Adya, Raghu; Ramanjaneya, Manjunath; Menon, Vinod; Bailey, Clifford J.; Brown, James; Lehnert, Hendrik and Randeva, Harpal S. (2009). In vivo and ex vivo regulation of visfatin production by leptin in human and murine adipose tissue: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Endocrinology, 150 (8), pp. 3530-3539.

Naujok, Ortwin; Francini, Flavio; Picton, Sally; Bailey, Clifford J; Lenzen, Sigurd and Jörns, Anne (2009). Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo. Diabetes/Metabolism Research and Reviews, 25 (5), pp. 464-476.

Bailey, C.J. and Day, C. (2009). Fixed-dose single tablet antidiabetic combinations. Diabetes, Obesity and Metabolism, 11 (6), pp. 527-533.

Day, Caroline and Bailey, Clifford J. (2009). HbA1c - changing units. British Journal of Diabetes and Vascular Disease, 9 (3), pp. 134-136.

Flatt, Peter R.; Day, Caroline and Bailey, Clifford J. (2009). Review: bariatric surgery:to treat diabesity. British Journal of Diabetes and Vascular Disease, 9 (3), pp. 103-107.

Day, Caroline and Bailey, Clifford J. (2009). Editorial : which weight loss diet? British Journal of Diabetes and Vascular Disease, 9 (2), p. 43.

Murray, H.E.; Paget, Michelle B.; Bailey, Clifford J. and Downing, R. (2009). Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system. Diabetologia, 52 (3), pp. 477-485.

Flatt, P.R.; Bailey, C.J. and Green, B.D. (2009). Recent advances in antidiabetic drug therapies targeting the enteroinsular axis. Current Drug Metabolism, 10 (2), pp. 125-137.

Krentz, Andrew J.; Patel, Mayank B. and Bailey, Clifford J. (2008). New drugs for type 2 diabetes mellitus:what is their place in therapy? Drugs, 68 (15), pp. 2131-2162.

Bailey, Cliff J. (2008). Metformin:a multitasking medication. Diabetes and Vascular Disease Research, 5 (3), p. 156.

Bailey, Clifford J. and Day, Caroline (2008). Glycaemic memory. British Journal of Diabetes and Vascular Disease, 8 (5), pp. 242-247.

Cooper, Michael B.; Al Majali, Khulood; Bailey, Clifford J. and Betteridge, D. John (2008). Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone. Clinical Endocrinology, 68 (5), pp. 738-746.

Bailey, Clifford J.; Barnett, Anthony H. and Petrie, John R. (2008). Value of glycaemic control in diabetes. The Lancet, 371 (9607), p. 116.

Naujok, Ortwin; Francini, Flavio; Picton, Sally; Jörns, Anne; Lenzen, Sigurd and Bailey, Clifford J. (2008). A new experimental protocol for preferential differentiation of mouse embryonic stem cells into insulin-producing cells. Cell Transplantation, 17 (10-11), pp. 1231-1242.

Alberti, K.G.M.M.; Bailey, C.J.; Blonde, L.; Felton, A.M.; Zimmet, P. and , and on behalf of the Global Partnership for Effective Diabetes M (2007). Partnering with governments and other institutions:driving change in diabetes care. International Journal of Cinical Practice, 61 (Suppl.), pp. 38-46.

Bailey, Clifford J. and Barnett, Anthony H. (2007). Why is Exubera being withdrawn? BMJ, 335 (7630), p. 1156.

O'Harte, Finbarr P.M.; Hunter, Kerry; Gault, Victor A.; Irwin, Nigel; Green, Brian D.; Greer, Brett; Harriott, Patrick; Bailey, Clifford J. and Flatt, Peter R. (2007). Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice. American Journal of Physiology, 292 (6), E1674-E1682.

Home, P.D.; Bailey, C.J.; Donaldson, J.; Chen, H. and Stewart, M.W. (2007). A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with type 2 diabetes. Diabetic Medicine, 24 (6), pp. 618-625.

Richardson, D.K.; Jones, R.B. and Bailey, C.J. (2006). The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes. Hormone and Metabolic Research, 38 (11), pp. 727-731.

Green, Brian D.; Lavery, Kerry S.; Irwin, Nigel; O'Harte, Finbarr P.M.; Harriott, Patrick; Greer, Brett; Bailey, Clifford J. and Flatt, Peter R. (2006). Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic β-cell function after 3-week daily administration in obese diabetic (ob/ob) mice. Journal of Pharmacology and Experimental Therapeutics, 318 (2), pp. 914-921.

Irwin, Nigel; O'Harte, Finbarr P.M.; Gault, Victor A.; Green, Brian D.; Greer, Brett; Harriott, Patrick; Bailey, Clifford J. and Flatt, Peter R. (2006). GIP(Lys16PAL) and GIP(LyS37PAL):novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potentia. Journal of Medicinal Chemistry, 49 (3), pp. 1047-1054.

Bailey, C.J. (2006). Fenofibrate and cardiovascular risk:a synopsis and commentary on (FIELD). Diabetic Medicine, 23 (2), pp. 109-112.

Bailey, C.J and Day, C. (2004). Avandamet:Combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. International Journal of Cinical Practice, 58 (9), pp. 867-876.

Bailey, C.J. and Turner, S.L. (2004). Glucosamine-induced insulin resistance in L6 muscle cells. Diabetes, Obesity and Metabolism, 6 (4), pp. 293-298.

Green, B.D.; Mooney, M.H.; Gault, V.A.; Irwin, N.; Bailey, C.J.; Harriott, P.; Greer, B.; O'Harte, F.P.M. and Flatt, P.R. (2004). N-terminal His7-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. Journal of Endocrinology, 180 (3), pp. 379-388.

Green, B.D.; Gault, V.A.; Mooney, M.H.; Irwin, N.; Harriott, P.; Greer, B.; Bailey, C.J.; O'Harte, F.P.M. and Flatt, P.R. (2004). Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues. Biological Chemistry, 385 (2), pp. 169-177.

Green, B.D.; Mooney, M.H.; Gault, V.A.; Irwin, N.; Bailey, C.J.; Harriott, P.; Greer, B.; Flatt, P.R. and O'Harte, F.P.M. (2004). Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39). Metabolism, 53 (2), pp. 252-259.

Green, B.D.; Gault, V.A.; Mooney, M.H.; Irwin, N.; Bailey, C.J.; Harriott, P.; Greer, B.; Flatt, P.R. and O'Harte, F.P.M. (2003). Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. Journal of Molecular Endocrinology, 31 (3), pp. 529-540.

Ahrén, B.; Gautier, J.-F.; Berria, R.; Stager, W.; Aronson, R. and Bailey, C.J. Pronounced reduction of postprandial glucagon by lixisenatide:a meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism, 16 (9), pp. 861-868.

Bailey, C.J. The current drug treatment landscape for diabetes and perspectives for the future. Clinical pharmacology and therapeutics, 98 (2), 170–184.

Bailey, C.J.; Iqbal, N.; T'joen, C. and List, J.F. Dapagliflozin monotherapy in drug-naïve patients with diabetes:a randomized-controlled trial of low-dose range. Diabetes, Obesity and Metabolism, 14 (10), pp. 951-959.

Bailey, C.J. and Kodack, M. Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65 (3), pp. 314-322.

Bailey, C.J.; Wilcock, C. and Scarpello, J.H.B. Metformin and the intestine. Diabetologia, 51 (8), pp. 1552-1553.

Bailey, Clifford J Renal glucose reabsorption inhibitors to treat diabetes. Trends in Pharmacological Sciences, 32 (2), pp. 63-71.

Bailey, Clifford J. Metformin:effects on micro and macrovascular complications in type 2 diabetes. Cardiovascular Drugs and Therapy, 22 (3), pp. 215-224.

Bailey, Clifford J. Under-treatment of type 2 diabetes:causes and outcomes of clinical inertia. International Journal of Clinical Practice, 70 (12), pp. 988-995.

Bailey, Clifford J.; Aschner, Pablo; del Prato, James; LaSalle, James; Ji, Linong and Matthaei, Stephan Individualized glycaemic targets and pharmacotherapy in type 2 diabetes. Diabetes and Vascular Disease Research, 10 (5), pp. 397-409.

Bailey, Clifford J. and Day, Caroline SGLT2 inhibitors:glucuretic treatment for type 2 diabetes. British Journal of Diabetes and Vascular Disease, 10 (4), pp. 193-199.

Bailey, Clifford J.; Gross, Jorge L.; Hennicken, Delphine; Iqbal, Nayyar; Mansfield, Traci A. and List, James F. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin:a randomized, double-blind, placebo-controlled 102-week trial. BMC Medicine, 11 (1),

Bailey, Clifford J.; Tahrani, Abd A. and Barnett, Anthony H. Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes and Endocrinology, 4 (4), pp. 350-359.

Bergenstal, Richard M.; Bailey, Clifford J. and Kendall, David M. Type 2 diabetes:assessing the relative risks and benefits of glucose-lowering medications. American Journal of Medicine, 123 (4), 374.e9-374.e18.

Blonde, Lawrence; Aschner, Pablo; Bailey, Clifford; Ji, Linong; Leiter, Lawrence A.; Matthaei, Stephan and , on behalf of the Global Partnership for Effective Diabetes Manag Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diabetes and Vascular Disease Research, 14 (3), pp. 172-183.

Day, Caroline and Bailey, Clifford J. Cardiovascular outcome trials in type 2 diabetes – 2015. Diabesity in practice, 4 (4), pp. 131-133.

Day, Caroline and Bailey, Clifford J. Obesity in the pathogenesis of type 2 diabetes. British Journal of Diabetes and Vascular Disease, 11 (2), pp. 55-61.

Flatt, Peter R.; Bailey, Clifford J. and Green, Brian D. Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes. Frontiers in Bioscience, 13 (10), pp. 3648-3660.

Fouqueray, Pascale; Pirags, Valdis; Inzucchi, Silvio E.; Bailey, Clifford J.; Schernthaner, Guntram; Diamant, Michaela and Lebovitz, Harold E. The efficacy and safety of imeglimin as add-on therapy in patientswith type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care, 36 (3), pp. 565-568.

Gao, Dan; Griffiths, Helen R. and Bailey, Clifford J. Oleate protects against palmitate-induced insulin resistance in L6 myotubes. British Journal of Nutrition, 102 (11), pp. 1557-1563.

Home, Philip; Riddle, Matthew; Cefalu, William T.; Bailey, Clifford J.; Bretzel, Reinhard G.; del Prato, Stefano; Leroith, Derek; Schernthaner, Guntram; van Gaal, Luc and Raz, Itamar Insulin therapy in people with type 2 diabetes:opportunities and challenges? Diabetes Care, 37 (6), pp. 1499-1508.

Inzucchi, Silvio E.; Lipska, Kasia J.; Mayo, Helen; Bailey, Clifford J. and McGuire, Darren K. Metformin in patients with type 2 diabetes and kidney disease:a systematic review. JAMA: Journal of the American Medical Association, 312 (24), pp. 2668-2675.

McKiney, Joan M.; Irwin, Nigel; Flatt, Peter R.; Bailey, Clifford J. and McClenaghan, Neville H. Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells. Biological Chemistry, 391 (12), pp. 1451-1459.

Pararasa, Chathyan; Bailey, Clifford J. and Griffiths, Helen R. Ageing, adipose tissue, fatty acids and inflammation. Biogerontology, 16 (2), pp. 235-248.

Rana, Karan S.; Arif, Muhammad; Hill, Eric J.; Aldred, Sarah; Nagel, David A.; Nevill, Alan; Randeva, Harpal S.; Bailey, Clifford J.; Bellary, Srikanth and Brown, James E. Plasma irisin levels predict telomere length in healthy adults. Age, 36 (2), pp. 995-1001.

Tahrani, Abd A.; Barnett, Anthony H. and Bailey, Clifford J. SGLT inhibitors in management of diabetes. The Lancet Diabetes and Endocrinology, 1 (2), pp. 140-151.

Wilding, John; Bailey, Clifford; Rigney, Una; Blak, Betina; Beekman, Wendy and Emmas, Cathy Glycated hemoglobin, body weight and blood pressure in type 2 diabetes patients initiating dapagliflozin treatment in primary care:a retrospective study. Diabetes Therapy, 7 (4), pp. 695-711.

Book Section

Bailey, Clifford J. (2013). Treatment with metformin. IN: The metabolic syndrome. Beck-Nielsen, Henning (ed.) Vienna (AT): Springer.

Day, Caroline and Bailey, Clifford J. (2011). Metformin. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Pioglitazone. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Bailey, Clifford J. (2011). Thiazolidinediones. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Biguanides. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Ciglitazone. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Rosiglitazone. IN: xPharm. Enna, S.J. and Bylund, David B. (eds) Elsevier.

Day, Caroline and Bailey, Clifford J. (2011). Troglitazone. IN: xPharm. Elsevier.

Bailey, Clifford J. (2010). Future drug treatments for type 2 diabetes. IN: Textbook of diabetes. Holt, Richard I.G.; Cockram, Clive S.; Flyvbjerg, Allan and Goldstein, Barry J. (eds) Wiley-Blackwell.

Bailey, Clifford J. and Krentz, Andrew J. (2010). Oral antidiabetic agents. IN: Textbook of diabetes. Holt, Richard I.G.; Cockram, Clive S.; Flyvbjerg, Allan and Goldstein, Barry J. (eds) Wiley-Blackwell.

Bailey, Clifford J. Metformin. IN: Therapy for diabetes mellitus and related disorders. Umpierrez, Guillermo E. (ed.) Alexandria, VA (US): American Diabetes Association.

Day, C. and Bailey, C. Ciglitazone. IN: Reference module in biomedical sciences. Elsevier.

Conference or Workshop Item

Gao, Dan; Griffiths, Helen R. and Bailey, Clifford J. Palmitate induces insulin resistance in monocytes and increases expression of the integrin CD11b. IN: Scientific Meeting of the Nutrition Society. 2007-07-01. (Unpublished)

Thesis

Bailey, Clifford J. (1973). Studies on the influence of sex hormones on glucose tolerance and insulin secretion in the rat. PHD thesis, Aston University.

This list was generated on Thu Jun 8 00:50:25 2017 BST.